Human embryonic stem (hES) cell production of heparan sulfate influences cell fate and pluripotency. Human ES cells remain pluripotent in vitro through the action of growth factors signaling, and the activity of these factors depends on interaction with specific receptors and also with heparan sulfate. Here, we tested the hypothesis that matrix-associated heparan sulfate is enough to maintain hES cells under low fibroblast growth factor-2 concentration in the absence of live feeder cells. To pursue this goal, we compared hES cells cultured either on coated plates containing live murine embryonic fibroblasts (MEFs) or on a matrix derived from ethanol-fixed MEFs. hES cells were analyzed for the expression of pluripotency markers and the ability to form embryoid bodies. hES cells cultured either on live mouse fibroblasts or onto a matrix derived from fixed fibroblasts expressed similar levels of Oct-4, SOX-2, Nanog, TRA-1-60 and SSEA-4, and they were also able to form cavitated embryoid bodies. Heparan sulfate-depleted matrix lost the ability to support the adherence and growth of hES cells, confirming that this glycosaminoglycan, bound to the extracellular matrix, is enough for the growth and attachment of hES cells. Finally, we observed that the ethanol-fixed matrix decreases by 30% the levels of Neu5Gc in hES cells, indicating that this procedure reduces xeno-contamination. Our data suggest that matrix-bound heparan sulfate is required for the growth and pluripotency of hES cells and that ethanol-fixed MEFs may be used as a "live cell"-free substrate for stem cells.
Human embryonic stem (hES) cell production of heparan sulfate influences cell fate and pluripotency. Human ES cells remain pluripotent in vitro through the action of growth factors signaling, and the activity of these factors depends on interaction with specific receptors and also with heparan sulfate. Here, we tested the hypothesis that matrix-associated heparan sulfate is enough to maintain hES cells under low fibroblast growth factor-2 concentration in the absence of live feeder cells. To pursue this goal, we compared hES cells cultured either on coated plates containing live murine embryonic fibroblasts (MEFs) or on a matrix derived from ethanol-fixed MEFs. hES cells were analyzed for the expression of pluripotency markers and the ability to form embryoid bodies. hES cells cultured either on live mouse fibroblasts or onto a matrix derived from fixed fibroblasts expressed similar levels of Oct-4, SOX-2, Nanog, TRA-1-60 and SSEA-4, and they were also able to form cavitated embryoid bodies.
Introduction
Since human embryonic stem (hES) cells were first derived (Thomson et al. 1998 ), a miscellany of protocols has been developed in order to optimize hES cell culture, 95 only for H9 cell line (Fernandes et al. 2010) . Changes in substrates for cell maintenance have been addressed in order to improve the microenvironment for hES cell growth (Ludwig and Thomson 2007; Hannoun et al. 2010; Kolhar et al. 2010; Meng et al. 2010) .
Signals mediated by interaction of growth factors with components of the extracellular matrix (ECM) are examples of substrate influence on cell dynamics. Fibroblast growth factor-2 (FGF-2) is, to this date, the most widely used factor to maintain the hES cells pluripotency loop (Fernandes et al. 2010) . This growth factor acts on hES cells by further leading to expression of the transcription factors Oct-4, SOX-2 and Nanog, which will act on pluripotency-related downstream genes. FGF-2 acts through binding with its receptor on the cell surface, and this interaction is enhanced by the co-receptor heparan sulfate (Jastrebova et al. 2010) .
Heparan sulfate proteoglycans are widely present on cell surface and secreted to the extracellular matrix. The secreted heparan sulfate proteoglycans stabilize FGF-2 by preventing its early degradation in cell culture (Levenstein et al. 2008) . The importance of heparan sulfate synthesized by ES cells for pluripotency maintenance and neural differentiation has also been reported (Sasaki et al. 2008; Kraushaar et al. 2010; Pickford et al. 2011) , including the role of cell surface heparan sulfate for ES cell fate. Nevertheless, these works have been performed on mouse ES cells, and the role of heparan sulfate for hES pluripotency and neural differentiation remains to be further investigated.
Reports on the use of glycosaminoglycans, such as hyaluronic acid hydrogels, have shown that these molecules may keep hES cells pluripotent in the presence of conditioned medium (Gerecht et al. 2007 ). On the other hand, screenings of synthetic substrates have shown that hES cells utilize their cell surface glycosaminoglycans to attach to heparin-binding peptide substrates (Klim et al. 2010) . While purified and combined extracellular matrix molecules also perform well on maintaining ES cells, these systems also use conditioned medium or high FGF-2 concentrations (Xu et al. 2001; Braam et al. 2008; Abraham et al. 2010) .
We therefore decided to investigate whether matrixassociated heparan sulfate would maintain hES cells under low FGF-2 concentration in the absence of live feeder fibroblasts. We verify that culturing hES cells on this MEF-derived heparan sulfate-rich matrix does not interfere with stem cell fate during embryoid body (EB) formation and further neural differentiation. Our data suggest that a heparan sulfatecontaining matrix synthesized by mouse fibroblasts is sufficient to keep hES cells pluripotent after long periods in vitro.
Results

Ethanol-fixed MEFs maintain hES cells adherence, growth and pluripotency
We first compared the growth of H9 cells co-cultured with mitomycin C-inactivated MEFs (control-MEF) and H9 cells transferred to ethanol-fixed MEFs (fixed-MEF). The main difference between these two conditions is ethanol fixation of fibroblasts for "fixed-MEF" condition, while control-MEF contains mitomycin C-treated live cells. The typical colony morphology was maintained when cells were grown on fixed-MEF matrices, forming round and packed colonies ( Figure 1A and B). We also compared mechanical and mild enzymatic treatment passaging methods (Supplementary data, Figure S1 ), and we observed that cells maintained in both conditions presented similar morphology. Therefore, we chose mild enzymatic treatment for cell passaging in this work. The growth rates were unaltered comparing control-MEF and fixed-MEF after 90 days in culture ( Figure 1C ). Finally, hES cells remained intact after freezing and thawing on their respective substrates.
After 90 days in culture, H9 cells cultured onto controlMEFs or on fixed-MEFs were compared regarding the expression of pluripotency markers. Oct-4, SOX-2 and Nanog were detected by immunofluorescence (Figure 1 D-K) , relative quantification polymerase chain reaction (PCR; Figure 1N -P) and SSEA-4 and TRA-1-60 were detected by cytometry analyses ( Figure 1M- . In addition, we also observed that chromosome stability was maintained in H9 cells after 90 days in culture ( Figure 1Q ). Similar results were obtained with hES cell line, BR-1 (Figure 2 ). Our data show that fixed-MEFs keep BR-1 pluripotency and growth rate, as observed for H9 cells.
To evaluate if the procedure used to fix cells with ethanol makes any feeder cell supportive for H9 growth, we replaced MEFs with human dental pulp (hDP) cells, which have not been described as a permissive hES cell feeder (Nosrat et al. 2004) . When cultured on fixed-hDP, H9 cells had their growth rate severely affected when compared with fixed-MEF (Supplementary data, Figure S2A ). Our results also confirmed that mitomycin C-inactivated hDP (control-hDP) cells were not able to maintain H9 cells morphology and growth (Supplementary data, Figure S2A and B). Loss of typical colony morphology could also be observed (Supplementary data, Figure S2C ), and loss of the ability to form embryoid bodies (Supplementary data, Figure S2D ) and to express pluripotency markers (Supplementary data, Figure S2E -H). These results indicate that fixed-hDP is not a suitable substrate for H9 cell growth. This observation indicates that the ability of fixed-MEF to support H9 growth is not an artifact generated by ethanol-based fixation of fixed-MEF.
H9 cells grown on fixed-MEF form embryoid bodies Human ES cells cultured with live MEFs and grown on fixed-MEFs maintained their ability to differentiate into embryoid bodies. They were able to form aggregates ( Figure 3A and B) that express the three germ layer markers, such as α-fetoprotein (endoderm), smooth muscle actin (mesoderm) and nestin (ectoderm), as verified by relative quantification PCR ( Figure 3C ). Despite having slightly different proportions of germ layers markers compared with control condition, H9 cells on fixed-MEF effectively respond to neural stimulation by raising expression of neural markers such as SOX-2, nestin and β-III tubulin ( Figure 3D -F), confirming their potential to differentiate into neural cells types.
Heparan sulfate adhered to the matrix is necessary for the survival of hES cells
We demonstrated that the matrix produced by MEFs (but not by hDP cells) supports the adherence and growth of hES cells. We investigated next if a particular heparan sulfate synthesized by MEFs may be responsible for these effects.
Glycosaminoglycan extracts from MEFs and hDP cells were fractionated on an ion-exchange chromatography ( Figure 4A ). Both cell types showed three major fractions, denominated as F1, F2 and F3. F1 migrates on agarose gel electrophoresis as a hyaluronic acid standard. F2 and F3 migrate as heparan sulfate and chondroitin sulfate standards, respectively ( Figure 4B and C). Fractions, F1 and F3, were cleaved by chondroitinase ABC, but resistant to deamination with nitrous acid. In an opposite way, fraction F2 was cleaved by nitrous acid deamination, but resistant to chondroitinase ABC digestion. These results indicate that fractions, F1, F2 and F3, are hyaluronic acid, heparan sulfate and chondroitin sulfate, respectively.
The proportions of the various glycosaminoglycans were estimated based on hexuronic acid content of the three fractions separated by ion-exchange chromatography. Noticeably, heparan sulfate corresponds to 23.9 ± 4.5% of the total glycosaminoglycans synthesized by MEFs and to 14.5 ± 2.1% of the hDP cells ( Figure 4D ). The proportions of chondroitin sulfate do not significantly vary between the two substrates. In conclusion, hDP cells possess similar proportion of hyaluronic acid and chondroitin sulfate and produce lower proportion of heparan sulfate, which, in addition to other factors, such as sulfation pattern, may be related with their inability to support hES cells.
To confirm that heparan sulfate from fixed-MEF is essential to support hES cells, we depleted the matrix from this particular glycosaminoglycan by nitrous acid treatment. We observed the complete depletion of heparan sulfate chains by immunostaining ( Figure 5 ). To verify that fixed-MEF remained intact after nitrous acid treatment, we also performed immunostaining for α-tubulin (Supplementary data, Figure S3 ), observing that staining was conserved even after nitrous acid treatment. Chondroitin sulfate was also removed by chondroitinase ABC digestion for comparison with heparan sulfate-depleted substrate ( Figure 6B and C, respectively). Depletion of heparan sulfate altered adherence and growth of H9 cells ( Figure 6A) , after 48 h, growth of H9 cells cultured on control-MEF, fixed-MEFs and chondroitin sulfate-depleted fixed-MEFs was very similar. In contrast, H9 cells cultured on heparan sulfatedepleted fixed-MEFs did not grow.
Fixed-MEF present less xeno-contamination properties compared with live MEFs MEFs express N-glycolylneuraminic acid (Neu5Gc) on their surface. The presence of this sialic acid is an evidence of the contamination of hES with animal compounds. Fixed-MEF may be considered "cell" free, due to the fact that there is no live cell feeder-stem cell interaction, although ES cells are still in physical contact with MEFs. Ethanol fixation promotes major protein denaturation making difficult to predict whether Matrix heparan sulfate maintains stem cells pluripotency hES cells growing onto fixed-MEF could absorb murine molecules. Therefore, H9 cells growing on fixed-MEF were evaluated for Neu5Gc content.
Due to the fact that MEFs naturally produce Neu5Gc and present a robust pattern of this sialic acid on their surface, they were used as a positive control. Total MEF population presents 64.0 ± 1.2% of Neu5Gc + cells, while control-MEF H9 cells present 38.3 ± 1.6% of Neu5Gc + cells and fixed-MEF H9 cells present 29.3 ± 1.9% of Neu5Gc + cells (Figure 7 ).
Discussion
This study shows that substrate-bound heparan sulfate immersed in an organized, protein-denatured, glycosaminoglycan-rich matrix plays a fundamental role in maintaining hES cells adhesion and growth properties.
MEF feeder layers have been used to maintain ES cells since the first ES cell lines derivations (Fernandes et al. 2010) . Despite the disadvantage of co-culturing murine (fibroblasts) and human (embryonic stem) cells, it is still considered a non-expensive and effective method for preserving hES cells pluripotency in vitro. MEF feeder layers efficiency relies on a number of parameters, such as method of production and age in culture. The work by Villa-Diaz et al. (2009) shows that irradiated MEFs in culture for 7 days become less supportive due to the secretion of factors that inhibit hES cell maintenance. The ethanol fixation method used to produce fixed-MEF avoids aging and secretion of factors that may negatively affect hES cells, while maintaining organized the extracellular matrix produced by the fibroblasts.
Matrigel and purified extracellular matrix proteins are alternative substrates to create a friendly environment for the maintenance and growth of hES cells. Nevertheless, in order to avoid the need of conditioned medium, i.e., feeder indirect dependence, both substrates require high FGF-2 concentrations, ranging from 40 to 120 ng/mL, in the culture medium (Levenstein et al. 2006 ) and/or additional factors (Peiffer et al. 2008; Yoon et al. 2010) , in order to keep pluripotency (Higuchi et al. 2011) . We hypothesize that the interaction between factors and these feeder-free substrates may be under optimal partially due to their unorganized matrix nature.
Heparan sulfate is widely present on the cell surface, extracellular matrix and as soluble proteoglycans. It can be produced from diverse sources, including fibroblasts such as MEFs, and its sulfation pattern is tightly regulated by intrinsic and extrinsic factors (Zhang 2010) , which makes heparan sulfate produced by different sources unique.
Several factors implicated in signaling pathways requested for the maintenance of hES cells pluripotency have been described (Xu et al. 2005; Ding et al. 2011) . However, there is very few data about how these factors interact with the culture microenvironment. For example, MEFs secrete proteoglycans that stabilize FGF-2 activity in culture (Levenstein et al. 2008) . Here, despite the absence of conditioned medium (therefore, the absence of soluble heparan sulfate proteoglycans) or high concentrations of FGF-2, we demonstrated that hES cells remain pluripotent when cultured on fixed-MEF. We hypothesize that heparan sulfate, which accumulates on the matrix, is enough to stabilize FGF-2 and/or to enhance its activity in culture, in addition to promoting hES cell adhesion. As substrate-bound heparan sulfate was found to be essential for hES maintenance. Although we cannot rule out that the existence of other heparan sulfate-binding essential molecules present in the medium, we consider FGF-2 a central molecule in pluripotency maintenance and a good candidate to explain heparan sulfate essential role in fixed-MEF efficiency.
The fixed-hDP substrate tested in this work has been shown to be ineffective for hES cell maintenance. This inability may be related to hDP-produced heparan sulfate, either due to its slightly lower levels compared with MEFs and/or its sulfation pattern, as MEFs and hDP are different cell types and may produce glycosaminoglycans with specific modifications. Overall, we believe that seeking permissive feeder cells and analyzing its glycosaminoglycans pattern may be a good strategy to find optimal glycan-based substrates for hES cells.
EB formation was also intact in H9 cells consistently cultured on fixed-MEF. The capacity to differentiate into representatives of the three germ layers was preserved, and nestin, SOX-2 and β-III tubulin expression after neural differentiation were consistent between control-and fixed-MEF conditions.
The lower levels of Neu5Gc were detected in hES cells growing onto fixed-MEF cultured H9 cells. Previous work has shown that the human body does not produce Neu5Gc; however, human cells are still able to internalize and link it to endogenous molecules (Martin et al. 2005) . Therefore, Neu5Gc absorption indicates xeno-contamination of hES cells. Components of the ES media, especially serum, are known to be the main source of Neu5Gc contamination (Martin et al. 2005) . We suggest that Neu5Gc detected in fixed-MEF H9 cells must originate preferentially from medium rather than from substrate itself.
In summary, our data indicate that matrix-bound heparan sulfate synthesized by MEFs is essential to keep pluripotency, possibly by facilitating hES cell adhesion and FGF-2 activity.
Materials and methods ES cell culture hES cell lines H9 (WiCell) and BR-1 (Fraga et al. 2011) were used in this work. H9 control cells were grown on mitomycin C-inactivated mouse embryonic fibroblasts (control-MEF) in high-glucose Dulbecco's modified Eagle's medium (DMEM)/ F12 medium supplemented with 20% Knockout™ Serum Replacement (KSR), 200 mM glutamine, 55 mM 2-mercaptoethanol, 1% non-essential amino acids (all from Gibco) and 8 ng/mL FGF-2 (Invitrogen). H9 cells cultured on fixed MEFs (fixed-MEF) were kept in the same ES cell medium combination previously described for at least 90 days to confirm substrate effectiveness on maintaining cells pluripotent for long periods. Both control-MEF and fixed-MEF H9 cells were enzymatically passaged by mild trypLE™ (Invitrogen) treatment, followed by cell detachment with a scraper. Mechanical passaging was also performed by the detachment of needle-cut colonies clumps with pipette tips. After 2 weeks, hES cells showed a consistent growth rate and could be passaged and expanded in the cell-free condition.
H9 cells were also cultured on control-(mitomycin C inactivated) and fixed-hDP cells under the same culture conditions as control-MEF and fixed-MEF.
BR-1 cells were initially cultured on matrigel (BD Biosciences) and mTeSR (Stem Cell Technologies) and then passed to fixed-MEF. BR-1 cells were kept on fixed-MEF for at least 60 days.
Substrates preparation Mitomycin C-inactivated MEFs were used as control substrate and were prepared according to Fernandes et al. (2009) . Briefly, MEFs were cultured until optimal confluence for hES cell culture, i.e., MEFs were plated at 2.65 × 10 4 cells/cm 2 and cultured for 24 h. Then, fibroblast proliferation was inactivated Expression of neural markers SOX-2, nestin and β-III tubulin, respectively by relative quantification PCR; black bars: 7-day-old hES embryoid bodies; gray bars: 14-day-old neural-induced embryoid bodies. Scale bar 100 µm for both images. *P < 0.01.
Matrix heparan sulfate maintains stem cells pluripotency by mitomycin C treatment (10 ng/mL-Sigma Aldrich). Control-MEFs were used for hES cell culture until 24 h after mitomycin C treatment.
Ethanol-fixed MEFs (fixed-MEF) were prepared as follows: MEFs were plated at 2.65 × 10 4 cells/cm 2 and cultured for 48 h to reach optimal confluence for good coverage of the plate (see Supplementary data, Figure S4 for visual reference). After reaching appropriated confluence, MEFs were rinsed once in phosphate-buffered saline and fixed in 70% ethanol. Fixed-MEF plates were sealed and stored at 4°C until use. In this work, plates up to 2 months old were used for hES cell culture. Fixed-MEF plates were at room temperature prior to hES cell plating.
Mitomycin C-treated hDP cells and fixed-hDP preparation followed the same protocol described for MEFs.
Growth curve
To compare the growth of H9 cells co-cultured with control-MEF or inoculated on fixed-MEF, cultures were kept on 12-well plates with an inoculum of 5 × 10 3 H9 cells/cm 2 for each group. On days 2-5, triplicate samples from each culture were collected by trypLE™ treatment, and cells were quantified using a Neubauer chamber. Similar protocol was used to compare the growth of H9 cells on control-hDP and fixed-hDP.
Immunostaining and cytometry
Immunostaining was performed on cells fixated in 4% paraformaldehyde for 15 min. Fixated cells were blocked in 2% bovine serum albumin (BSA) for 1 h, incubated with primary antibody overnight at room temperature and, finally, incubated with secondary antibody for 1 h. Cells nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI) prior to slide mounting. Nuclei markers were quantified using ImageJ software. Cell surface markers quantification was assessed by cytometric analyses performed on a FACSCalibur cytometer (BD Biosciences). Cells were individualized by trypLE™ treatment, fixated in 4% paraformaldehyde for 10 min and incubated in primary and secondary antibodies for 1 h each.
Antibodies against the following molecules were used for immunostaining and cytometry analyses, Oct-4 (Santa Cruz Biotechnologies), Nanog (Cell Signaling Technology), SOX-2, SSEA-4, TRA-1-60, α-tubulin (all from Chemicon) and Heparan sulfate (Seikagaku). Neu5Gc staining was performed with the Gc-free basic kit (Sialix). MEFs were used as positive control for Neu5Gc presence and were analyzed 2 days after thawing. Negative controls were performed with antibody respective immunoglobulin isotype.
Relative quantification PCR Relative quantification PCR was performed using a SYBR Green Master Mix (Applied Biosystems). The amplifying reaction cycles were: 60°C for 60 s followed by 95°C for 15 s, 45 cycles were performed. Samples were normalized by glyceraldehyde 3-phosphate dehydrogenase (GAPDH) expression. RNase-free water was used as negative control, and dissociation curves were also obtained for all reactions. Primers sequences are listed in Supplementary data, Table. Chromosome counting Chromosome counting was performed according to Sartore et al. (2011) , briefly, cells were incubated with 0.1 mg/mL KaryoMAX colcemid (Gibco Invitrogen) for 6 h, following dissociation with trypsin/EDTA 0.05% and incubated for 15 min in 75 mM KCl solution at 37°C. Cells were fixed in methanol/glacial acetic acid 3:1 (v:v) solution (Merck). The cell suspension was washed with the fixative solution and then spread onto glass slides. The slides were quickly exposed to water in order to maximize cell spreading and bursting. Chromosomes were stained with DAPI. Slides were examined on a fluorescence microscope (Nikon Eclipse 80i). At least 60 metaphases (H9 cell line) and 25 metaphases (BR-1 cell line) were counted on each condition. Late passage H9 cell line modal number of 45/46/47 was considered for chromosomal stability.
EB formation and analysis
The assessment of spontaneous differentiation was performed by EB formation assay. Confluent H9 cells co-cultured with control-MEF and grown on fixed-MEF were re-suspended by trypLE™ treatment, plated at 3.6 × 10 5 cells/mL and cultured for 7 and 14 days in non-adherent dishes. The 7-day group Matrix heparan sulfate maintains stem cells pluripotency was cultured in EB medium (ES medium without FGF-2 and 15% KSR). The 14-day group was cultured in EB medium for the first 7 days, and in neural induction medium (highglucose DMEM/F12 medium supplemented with 1% nonessential amino acids, 1% N2 supplement [all from Gibco], 20 µg/mL heparin [Cristália] and 0.5 ng/mL FGF-2 [Invitrogen]) for the last 7 days. Medium was changed in alternate days.
Cells that underwent EB formation assay were analyzed for the following parameters: ability to form EBs and mRNA expression of germ layer and early neural markers molecules. Markers expression was analyzed by relative quantification PCR.
Glycosaminoglycan extraction
Glycosaminoglycans extraction was performed in three independent culture batches of MEFs and hDP cells. For each batch, MEFs and hDP cells from 10 T150 flasks were collected and processed as follows. MEFs and hDP were cultured in T150 flasks until optimal confluence. Then, cells were incubated with trypLE™ for 15 min in order to solubilize the cell surface glycosaminoglycan chains. The solution was centrifuged at 1700 × g for 30 min. The precipitate was further digested by papain (Sigma). The resulting supernatants of the two extractions were mixed. The glycosaminoglycans in this solution were further purified by ion-exchange chromatography.
Ion-exchange chromatography Soluble extracts containing glycosaminoglycans were filtered and injected into a MonoQ ion-exchange column linked to a HPLC system (Amersham Bioscience). Glycosaminoglycans were separated by NaCl gradient ranging from 0 to 2 M in 30 mL of 20 mM Tris-HCl pH 8.0. Fractions of 500 µL were collected and checked for hexuronic acid by the carbazole assay (Bitter and Muir 1962) . Fractions containing glycosaminoglycans were pooled and precipitated with 70% ethanol for 12 h at −20°C. The pellet was collected by centrifugation and re-suspended in distilled water.
Agarose gel electrophoresis
Glycosaminoglycans were analyzed on agarose gel electrophoresis, as described in Werneck et al. (1999) . Gels were prepared using 0.5% agarose in 50 mM 1,3-diaminopropane pH 9.0. Glycosaminoglycans separation, i.e. bands formation, was achieved after 90 min at 100 V electric potential. Gels were then processed for glycosaminoglycan precipitation in a 1% Cetavlon solution for 24 h and dried by low heat exposure for approximately 3 h. Gels were stained in 1% toluidine blue. A mixture of commercially available glycosaminoglycans (Sigma) was used as migration standard for gel bands identification.
Removal of heparan sulfate and chondroitin sulfate from the ECM Fixed-MEF substrates were enzymatically and chemically treated for the removal of specific glycosaminoglycans. Heparan sulfate was cleaved by nitrous acid deamination at pH 1.5 (Werneck et al. 1999) . After 20 min, the matrix was water rinsed, sterilized and used for cell plating. In parallel, chondroitin sulfate was removed by treatment with 10 mU/cm 2 chondroitinase ABC (Seikagaku) for 2 h after which water rinsed and sterilized substrates were also used for cell plating.
hES cell attachment on glycosaminoglycan-depleted MEFs To assess hES cells attachment to heparan sulfate-or chondroitin sulfate-depleted fixed-MEF, H9 cells were plated at 5 × 10 3 cells/cm 2 and collected by trypLE™ treatment for counting on Neubauer chamber after 2 days in culture.
Statistical analysis
Student's t-test was performed on samples (SigmaPlot software) in order to assess differences between groups.
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